SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
260
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aegean Marine Petroleum Network Inc. of Class Action Lawsuit and Upcoming Deadline – ANW

NEW YORK, June 23, 2018 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Aegean Marine Petroleum Network Inc. (“Aegean” or the “Company”) (NYSE: ANW ) and certain of its officers.  The class action, filed in United States District Court, Southern District of New York, and docketed under 18-cv-05165, is on behalf  of a class consisting of all persons other than Defendants who purchased or otherwise acquired Aegean securities between April 28, 2016 and June 4, 2018, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased Aegean securities between April 28, 2016, and June 4, 2018, both dates inclusive, you have until August 6, 2018, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com .  To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

[Click here to join this class action]

Aegean Marine Petroleum Network Inc. supplies and markets refined marine fuel and lubricants to ships in port and at sea. The Company also owns and operates a fleet of bunkering tankers in multiple jurisdictions.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Aegean had improperly accounted for an approximate $200 million of accounts receivable as of December 31, 2017; (ii) Aegean failed to maintain effective internal control over financial reporting; and (iii) as a result of the foregoing, Defendants’ statements about Aegean’s business, operations, and prospects, were materially false and misleading at all relevant times.

On May 22, 2018, Aegean Marine announced an internal review of its financial reporting.  Then, on June 4, 2018, Aegean Marine announced its preliminary findings from the review, including that “approximately $200 million of accounts receivable at December 31, 2017 will need to be written off.”  Aegean Marine further advised investors that certain “transactions that gave rise to the accounts receivable . . . may have been, in full or in part, without economic substance and improperly accounted for in contravention of the Company’s normal policies and procedures.” 

On this news, Aegean Marine’s share price fell $2.15, or 75.43%, to close at $0.70 on June 5, 2018.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT: Robert S. Willoughby Pomerantz LLP rswilloughby@pomlaw.com 888-476-6529 ext. 9980

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CMC Declares Dividend Amid Complex Outlook

Updated Category News Views 18

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 19

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 13

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
AtWork Welcomes Franchise Vet Sarah Goehring

Updated Category News Views 18

A Strategic Move for AtWork There's a new heavyweight at AtWork, a name that's been catching attention in the franchise biz lately—Sarah Goehring. This isn't just another appointment; it's a signal flare for AtWork's ambitions. With Goehring, they're doubling down on scaling their operation and drawing in more franchise players who are ready to hit the ground running....

Continue Reading
Home Buying: Unmasking All the Real Budget Costs

Updated Category News Views 10

Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 21

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Simple Home Upgrades That Boost Value Fast

Updated Category News Views 6

Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...

Continue Reading
OmniActive's Fenavari: A New Era in Women's Health

Updated Category News Views 32

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Continue Reading
Trial for Former OB/GYN Arthur Park Begins in Bakersfield

Updated Category News Views 6

A Somber Day for Justice in Bakersfield There’s a buzz in the air, thick with anticipation and grief, as a trial seven years in the making kicks off in Bakersfield. It’s a significant affair, marking a turning point in a saga that’s shadowed the region with untold grief and unresolved accountability. We’re talking about the trial of Arthur Park, a former OB/GYN,...

Continue Reading

Top 5 Most Recently Viewed Articles

WiMi Hologram Cloud's Blockchain-Driven Cloud Service Innovation

Updated Category News Views 140

WiMi Hologram Cloud's Blockchain-Driven Service Innovation WiMi Hologram Cloud Inc. (NASDAQ: WiMi), a premier global provider of Hologram Augmented Reality (AR) Technology, has unveiled a transformative Cloud Service Trust Interaction Framework leveraging Blockchain Technology. This innovative framework is designed to improve service credibility while optimizing user...

Continue Reading
Delicious Bagel Chips Now Available Online from Eccentric Bagel

Updated Category News Views 227

Welcome to Eccentric Bagel's Online Shop Prepare to treat yourself to something special from The Eccentric Bagel, where our innovative flavor creations are now available online for everyone to enjoy. We’re excited to introduce our online store, giving you easy access to our one-of-a-kind bagel chips, which can be shipped to customers all over the country. This is a...

Continue Reading
Understanding Hut 8 Corp's Market Dynamics and Trends

Updated Category News Views 165

Insights into Hut 8 Corp's Market Support Hut 8 Corp (NYSE:HUT) has recently seen notable changes in its short interest, raising questions about its market support. The short interest, representing shares sold short, has grown by 5.45% since the latest report. Currently, there are approximately 17.39 million shares sold short, which constitutes around 17.8% of all shares...

Continue Reading
ViCentra Introduces Smartphone-Controlled Diabetes Solution by 2026

Updated Category News Views 213

ViCentra's Upcoming Smartphone-Based Therapy for Diabetes ViCentra, renowned for its innovative Kaleido insulin patch pump, is set to revolutionize diabetes management with the upcoming launch of its smartphone-controlled closed loop therapy. The exciting development is expected to debut in early 2026, promising a more user-friendly approach to insulin delivery and...

Continue Reading
Short Interest Trends and Market Sentiment for Linde PLC

Updated Category News Views 111

Understanding Short Interest for Linde PLC Linde PLC (NYSE: LIN) has shown notable shifts in its short interest recently. The short percent of float for Linde has decreased by 4.59%, indicating fresh dynamics in how traders perceive this leading industrial gas company. Current reports show that there are approximately 4.90 million shares sold short, which represents 1.04%...

Continue Reading